MURRIETA, Calif. , July 19, 2011 /PRNewswire/ -- COPAN will be holding a workshop on Automated Specimen Processing in Microbiology during AACC's Annual Meeting. The workshop will be held at the Hyatt Regency Atlanta on Tuesday, July 26th at ...
Web-based smart-match tool to connect volunteers with clinical trials launches in beta NEW YORK, July 14, 2011 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research today launched the beta version of Fox Trial ...
Pacific Reproductive Center's new aCGH lab delivers fresh hope for would-be moms at risk of miscarriages & birth defects LOS ANGELES , May 9, 2011 /PRNewswire/ -- Pacific Reproductive Center (PRC), a southern California fertility ...
ROCKVILLE, Md. , May 9, 2011 /PRNewswire-USNewswire/ -- Intensive care units (ICUs) in both large and small hospitals stopped central line-associated bloodstream infections for up to 2 years after using a targeted quality improvement ...
CHICAGO , May 9, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced the presentation of two abstracts at the 2011 Digestive Disease Week (DDW) conference highlighting additional analyses of data from Phase 3 ...
RED BANK, N.J. , May 9, 2011 /PRNewswire-USNewswire/ -- When it comes to navigating your health in today's world, do you know where to go? A new iPhone app can help keep you on course. HealthyWomen, the nation's leading nonprofit health ...
NEW YORK , May 9, 2011 /PRNewswire/ -- As part of a major update to the FitnessBuilder App for iPad, iPhone and iPod touch, PumpOne announced its new FitnessBuilder PT tool is now available for physical, occupational and orthopedic ...
- Hires Pharmaceuticals Expert Jeffrey Alan Hovden - PALO ALTO, Calif. , May 9, 2011 /PRNewswire/ -- Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises ...
SUNNYVALE, Calif. , May 9, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Securities and Exchange Commission has declared effective the company's Form ...
Study Findings Show Efficacy of STELARA in Patients Who Previously Had Inadequate Response to Tumor Necrosis Factor Antagonists CHICAGO , May 9, 2011 /PRNewswire/ -- New study findings showed that treatment with STELARA® (ustekinumab) ...
Bharat Biotech, in collaboration with Biofabri, a Spanish biopharmaceutical firm, is conducting trials for the first live attenuated vaccine MTBVAC ( ) derived from a human strain of Mycobacterium tuberculosis. These trials aim to assess the safety and ...
A multisite clinical trial offers promising outcomes for patients with metastatic and recurrent uterine cancer, also known as endometrial cancer. Presented at the annual meeting of the Society of Gynecologic Oncologists, the study compiled data from ...
Researchers at the University of Oxford in the UK have initiated the first human clinical trial to evaluate ChAdOx1 NipahB vaccine designed to safeguard individuals against the deadly Nipah virus . ( ) ChAdOx1 NipahB Vaccine Trial with 51 Participants to Combat Nipah Virus Threat Fifty-one people aged 18 to 55 will participate in the ...
The stromal processing peptidase (SPP), a chloroplast plant enzyme, reduces the clumping of proteins that cause the pathogenic alterations in models of Huntingtons disease in human cells and the nematode Caenorhabditis elegans ( ). ...
A group of US researchers, who first conducted an ‘ artificial womb ’ experiment in lamb, are now seeking Food and Drug Administration (FDA) approval for its tests on humans ( ). This could potentially reduce deaths and disability for babies ...
Subscribe to our Free Newsletters!